Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Aviszus

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plos One|January 24, 2017
Immunogenicity of Isogenic IgG in Aggregates and Immune ComplexesJ Benjamin St Clair, Thiago Detanico, Katja Aviszus, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2022
Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor γManale El Kharbili, Katja Aviszus, Sarah K Sasse, et al.
Immunity|December 19, 2006
Identification of anergic B cells within a wild-type repertoireKevin T Merrell, Robert J Benschop, Stephen B Gauld, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patientsHaolin Liu, Katja Aviszus, Pearlanne Zelarney, et al.
ERJ Open Research|August 16, 2023
Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patientsHaolin Liu, Katja Aviszus, Pearlanne Zelarney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2012
Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cellsKatja Aviszus, Megan K L Macleod, Greg A Kirchenbaum, et al.
Journal of Lipid Research|June 23, 2026
Fatty acid-binding protein 5 deficiency impairs alveolar macrophage function and metabolismJack H Ratliff, Katja Aviszus, Sophia Addi, et al.
Mabs|June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab <i>in vitro</i>Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab <i>in vitro</i>Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
International Journal of Molecular Sciences|October 14, 2022
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral ImmunityHaolin Liu, Pengcheng Wei, Katja Aviszus, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|January 24, 2017
Immunogenicity of Isogenic IgG in Aggregates and Immune ComplexesJ Benjamin St Clair, Thiago Detanico, Katja Aviszus, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2022
Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor γManale El Kharbili, Katja Aviszus, Sarah K Sasse, et al.
Immunity|December 19, 2006
Identification of anergic B cells within a wild-type repertoireKevin T Merrell, Robert J Benschop, Stephen B Gauld, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patientsHaolin Liu, Katja Aviszus, Pearlanne Zelarney, et al.
ERJ Open Research|August 16, 2023
Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patientsHaolin Liu, Katja Aviszus, Pearlanne Zelarney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2012
Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cellsKatja Aviszus, Megan K L Macleod, Greg A Kirchenbaum, et al.
Journal of Lipid Research|June 23, 2026
Fatty acid-binding protein 5 deficiency impairs alveolar macrophage function and metabolismJack H Ratliff, Katja Aviszus, Sophia Addi, et al.
Mabs|June 2, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab <i>in vitro</i>Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab <i>in vitro</i>Haolin Liu, Pengcheng Wei, Qianqian Zhang, et al.
International Journal of Molecular Sciences|October 14, 2022
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral ImmunityHaolin Liu, Pengcheng Wei, Katja Aviszus, et al.
Pageof 3